Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
94 participants
INTERVENTIONAL
2015-08-11
2018-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors
NCT00266292
Fish Oils and Soybean Lecithin Supplementation Modulate Immune Function in Runners
NCT03364699
Fish Oil T Cell Function
NCT02775084
Effects of n3 LC PUFAs on Inflammatory, Immune and Senescence Features in Polyvascular Older Subjects (OMSAGE)
NCT06666101
Immune Modulation by Parenteral Lipids
NCT00734916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
n-3 fatty acid enriched formula
Those assigned to the n3EN group received vegetable n-3 fatty acid enriched formula by tube feeding (product; Yonsei Dairy Co., Seoul, South Korea).
vegetable (canola, flaxseed) derived n-3 fatty acid
vegetable (canola, flaxseed) derived n-3 fatty acid
vegetable (canola, flaxseed) derived n-3 fatty acid was used for fat source.
soybean oil used formula
Patients assigned to the control group received a soybean used formula by tube feeding.
soybean used formula
soybean oil
soybean oil used formula
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vegetable (canola, flaxseed) derived n-3 fatty acid
vegetable (canola, flaxseed) derived n-3 fatty acid was used for fat source.
soybean oil
soybean oil used formula
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with hepatic impairment (total bilirubin concentration\> 3.5 mg / dl)
* Patients with renal impairment (serum creatinine concentration\> 3 mg / dl or requiring peritoneal or hemodialysis) diabetic patients
* Patients who are undergoing chemotherapy or who are within 1 month of the end of chemotherapy
* Patients whose life expectancy is less than 1 month
* Pregnant women and women who are pregnant
19 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jong Ho Lee
Professor, Principal Investigator
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.